VIRO — ViroGates A/S Share Price
0.000.00%
Last trade - 00:00- DKK38.80m
- DKK28.07m
- DKK5.58m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.28 | ||
| Price to Tang. Book | 2.28 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6.95 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -56.32% | ||
| Return on Equity | -73.1% | ||
| Operating Margin | -225.08% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | DKKm | 3.58 | 5.35 | 7.66 | 10.15 | 5.58 | n/a | n/a | 10.98% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ViroGates A/S is a Denmark-based medical technology company. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflects immune activation and is increased in such infectious diseases as HIV-1-infection, malaria, tuberculosis, Streptococcus pneumonia bacteraemia, sepsis, pneumococcal pneumonia and bacterial and viral CNS infection. Also, high suPAR levels are associated with increased inflammation, disease progression and risk of mortality. Thus, measuring suPAR levels serves as a marker to determine chances for survival upon hospital admission, as well as for monitoring for prevention of disease progression and earlier intervention time point. suPARnostic has two versions: Quantitative Point of Care Quick Triage test, which serves for patient triage in acute care, and Quantitative ELISA Assay that aims at clinical routine use.
Directors
- Lars Kongsbak CHM (59)
- Jakob Knudsen CEO (52)
- Mark Hvidberg da Silva CFO (30)
- Jesper Eugen-Olsen CSO (57)
- Thomas Krarup VPR (57)
- Lars Krogsgaard DRC (54)
- Joergen Thorball DRC (58)
- Bernd Uder DRC (63)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 1st, 2000
- Public Since
- June 26th, 2018
- No. of Employees
- 10
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange - Copenhagen
- Shares in Issue
- 6,444,969
- Address
- Banevaenget 13, BIRKEROED, 3460
- Web
- https://www.virogates.com/
- Phone
- Auditors
- BDO Statsautoriseret Revisionsaktieselskab
Upcoming Events for VIRO
Similar to VIRO
Genmab A/S
OMX Nordic Exchange - Copenhagen
Gubra A/S
OMX Nordic Exchange - Copenhagen
Orphazyme A/S
OMX Nordic Exchange - Copenhagen
Zealand Pharma A/S
OMX Nordic Exchange - Copenhagen
FAQ
What is the ViroGates A/S share price?
As of Today at 19:23 UTC, shares in ViroGates A/S are trading at DKK6.02. This share price information is delayed by 15 minutes.
How has the ViroGates A/S share price performed this year?
Shares in ViroGates A/S last closed at DKK6.02 and the price had moved by -70.76% over the past 365 days. In terms of relative price strength the ViroGates A/S share price has underperformed the FTSE Global All Cap Index by -73.03% over the past year.
What are the analyst and broker recommendations for ViroGates A/S?
There is no consensus recommendation for this security.
What is the ViroGates A/S dividend yield?
ViroGates A/S does not currently pay a dividend.
Does ViroGates A/S pay a dividend?
ViroGates A/S does not currently pay a dividend.
When does ViroGates A/S next pay dividends?
ViroGates A/S does not currently pay a dividend.
How do I buy ViroGates A/S shares?
To buy shares in ViroGates A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of ViroGates A/S?
As of the previous close price of DKK6.02, shares in ViroGates A/S had a market capitalisation of DKK38.80m.
Where are ViroGates A/S shares listed?
Here are the trading details for ViroGates A/S:
- Country of listing: Denmark
- Exchange: CPH
- Ticker Symbol: VIRO
What kind of share is ViroGates A/S?
Based on an overall assessment of its quality, value and momentum ViroGates A/S is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a ViroGates A/S share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the ViroGates A/S share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ViroGates A/S. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -62.9%.
As of the last closing price of DKK6.02, shares in ViroGates A/S were trading -46.39% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the ViroGates A/S PE Ratio?
The ViroGates A/S PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at DKK6.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of ViroGates A/S?
ViroGates A/S' management team is headed by:
- Lars Kongsbak - CHM
- Jakob Knudsen - CEO
- Mark Hvidberg da Silva - CFO
- Jesper Eugen-Olsen - CSO
- Thomas Krarup - VPR
- Lars Krogsgaard - DRC
- Joergen Thorball - DRC
- Bernd Uder - DRC